France· FR:61722693
NALADOR 500 microgrammes, lyophilisat pour usage parentéral
A sulproston product containing sulprostone, registered in France by TEOFARMA. The same ATC class is registered in 4 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Sulproston is registered in 4 of 19 countries.
Countries holding a registration under ATC G02AD05 (sulproston), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 3 of them publish a price we can compare per daily dose
Sulproston · ATC G02AD05
4 / 19 countries
- Finlandprice
- Franceprice
- Netherlands
- Switzerlandprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- SULPROSTONE
- Manufacturer
- TEOFARMA
- Country
- France (FR)
- ATC code
- G02AD05
- ATC class
- Sulproston
- Defined daily dose
- 0.5 mg, P
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip1334009550796131 flacon(s) en verre jaune(brun) de 2 ml
- cip1334009555252021 ampoule(s) en verre de 2 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sulproston in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsNalador-500, poeder voor oplossing voor infusie 500 mcgBModesto B.V.
- SwitzerlandNalador, liofilizzatoFARMACEUTICA TEOFARMA SUISSE SA
- GermanyNalador-500Teofarma S.R.L.
- FinlandNaladorSchering Oy
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Austria · Nalador
- Germany · Nalador-500
- Hungary · Nalador
- Italy · Nalador
- Netherlands · Nalador
- Portugal · Nalador 500
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/993c20b3-9dbd-455a-a9bf-e52f5d44e2e9 GET /v1/drugs/993c20b3-9dbd-455a-a9bf-e52f5d44e2e9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61722693",
"date_amm": "1985-11-26",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "SULPROSTONE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "lyophilisat pour usage parentéral",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about sulproston.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.